cocaine

Documents about cocaine

• Aripiprazole to Reduce Cocaine Relapse#911138ClinicalTrials.gov
• Pramipexole as a Treatment for Cocaine Dependence#801420ClinicalTrials.gov
• Safety Study of a Disrupted Adenovirus (Ad) Serotype Cocaine Vaccine for Cocaine-dependent Individuals#845700ClinicalTrials.gov
• The Effects of Doxazosin on the Cardiovascular and Subjective Effects of Cocaine#868806ClinicalTrials.gov
• Phendimetrazine and Cocaine#860578ClinicalTrials.gov
• Venlafaxine to Reduce Cocaine Dependence in Depressed Individuals#886619ClinicalTrials.gov
• The Effect of Yohimbine on Cocaine Cue Reactivity#994474ClinicalTrials.gov
• Interaction Between Vanoxerine (GBR 12909) and Cocaine in Cocaine Dependent Individuals#862760ClinicalTrials.gov
• Carbamazepine Treatment for Cocaine Dependence - 5#897329ClinicalTrials.gov
• Use of Intranasal Oxytocin During Detoxification of Crack Cocaine#968664ClinicalTrials.gov
• Piracetam for Treatment of Cocaine Addiction, Phase II - 4#835464ClinicalTrials.gov
• Dextroamphetamine-Cocaine Behavioral Intervention - 5#842910ClinicalTrials.gov
• Efficacy of Mirtazapine in Depressed Cocaine Dependent Subjects#853806ClinicalTrials.gov
• Pilot Trial of Acamprosate for the Treatment of Cocaine Dependence#885946ClinicalTrials.gov
• Propranolol for Treatment of Cocaine Addiction - 2#827305ClinicalTrials.gov
• Pilot Study of Lisdexamfetamine for Treatment of Cocaine Dependence#982216ClinicalTrials.gov
• Cocaine Use Reduction With Buprenorphine#916847ClinicalTrials.gov
• IV Cocaine Abuse: A Laboratory Model - 4#811370ClinicalTrials.gov
• Therapeutic Potential of Kappa-Opioids Against Cocaine - 1#845624ClinicalTrials.gov
• SXC-2023 Cocaine Interaction Study#849325ClinicalTrials.gov
• Gepirone vs Placebo in Treatment of Cocaine Dependence - 3#966195ClinicalTrials.gov
• Open-Label Pilot Study of Lisdexamfetamine for Cocaine Dependence#897439ClinicalTrials.gov
• M-CPP and Fenfluramine in Cocaine Addicts - 3#982201ClinicalTrials.gov
• PET Imaging in Cocaine Self Administration#885976ClinicalTrials.gov
• Human Dopamine Transported Imaging in Cocaine Abuse: 2 - 2#874001ClinicalTrials.gov
• Assessment of Potential Interactions Between Cocaine and RPR 102681 - 1#912988ClinicalTrials.gov
• Selegiline Transdermal System for the Treatment of Cocaine Dependence - 1#979662ClinicalTrials.gov
• Vitamin D and Cocaine Administration#835701ClinicalTrials.gov
• New Approaches to Cocaine Abuse Medications (A) - 6#801814ClinicalTrials.gov
• Tiagabine, Sertraline, or Donepezil for the Treatment of Cocaine Dependence - 9#853828ClinicalTrials.gov
• Study to Assess Safety, Tolerability, and Interactions of Cocaine and Oral AFQ056#969790ClinicalTrials.gov
• Transcranial Magnetic Stimulation for Cocaine Addiction#863291ClinicalTrials.gov
• Exenatide For Reducing the Reinforcing Effects of Cocaine#121233ClinicalTrials.gov
• Drug Test Detection of Cocaine for Nasal Intubation#803503ClinicalTrials.gov
• A Study of the Relationship Between Disulfiram and Cocaine Self-administration.#801667ClinicalTrials.gov
• Non-Treatment Study of Factors Affecting Cocaine Drug Choice#865579ClinicalTrials.gov
• Cocaine Cue-reactivity Incubation Study#880203ClinicalTrials.gov
• Resperine, Gabapentin, or Lamotrigine for the Treatment of Cocaine Dependence: 2 - 7#892211ClinicalTrials.gov
• Cocaine-induced oronasal communication of the midline of the palate: A case report#406765Repositorio Universidad del Desarrollo
• Nefazodone in the Treatment of Cocaine Dependence and Depression - 4#802884ClinicalTrials.gov
• Cocaine disrupts action flexibility via glucocorticoid receptors#649087UNC Dataverse Dataverse OAI Archive
• Progesterone and Atomoxetine for Cocaine Cessation#890308ClinicalTrials.gov
• Glutamatergic Modulation of Cocaine-related Deficits#906621ClinicalTrials.gov
• Clavulanic Acid for the Treatment of Cocaine Use Disorder#969682ClinicalTrials.gov
• A Transtheoretical Model Group Therapy for Cocaine#906392ClinicalTrials.gov
• Probability of fentanyl adulteration in cocaine selectively decreases cocaine demand.#154242NCBI PubMed Central
• A Study of Baclofen ER#835416ClinicalTrials.gov
• Psilocybin-facilitated Treatment for Cocaine Use#894728ClinicalTrials.gov
• Buprenorphine Naltrexone-P1 A-Cocaine#992054ClinicalTrials.gov
• Tirzepatide attenuates mesolimbic cocaine-evoked dopamine levels and reduces cocaine taking, motivation and seeking behaviours in male rodents#5584Europe PMC